R. Vembu, S. Nellepalli, M. Pandurangi, S. Nagireddy
{"title":"两剂激动剂对辅助生殖技术结果的影响","authors":"R. Vembu, S. Nellepalli, M. Pandurangi, S. Nagireddy","doi":"10.5005/jp-journals-10016-1255","DOIUrl":null,"url":null,"abstract":"women in the age-group of 21–42 years, identified as hyperresponders by ovarian reserve markers, anti-Mullerian Hormone [AMH ≥3.5 ng/mL and or antral follicle count (AFC) of ≥20, >14 intermediary follicles and/or a high serum estradiol (E2) level (>3500 pg/mL] on the day of trigger, receiving two doses of agonist trigger 12-hour apart were included. Women with hypothalamic amenorrhea and hypogonadotropic-hypogonadism were excluded. So 86 women fulfilling the selection criteria were analyzed. Ovarian reserve assessment (determined by AMH levels, AFC on day 2 or 3 of menstrual cycle) was done after detailed history and clinical examination. In t r o d u c t I o n","PeriodicalId":38998,"journal":{"name":"International Journal of Infertility and Fetal Medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Two Doses of Agonist Trigger on Assisted Reproductive Technology Outcome\",\"authors\":\"R. Vembu, S. Nellepalli, M. Pandurangi, S. Nagireddy\",\"doi\":\"10.5005/jp-journals-10016-1255\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"women in the age-group of 21–42 years, identified as hyperresponders by ovarian reserve markers, anti-Mullerian Hormone [AMH ≥3.5 ng/mL and or antral follicle count (AFC) of ≥20, >14 intermediary follicles and/or a high serum estradiol (E2) level (>3500 pg/mL] on the day of trigger, receiving two doses of agonist trigger 12-hour apart were included. Women with hypothalamic amenorrhea and hypogonadotropic-hypogonadism were excluded. So 86 women fulfilling the selection criteria were analyzed. Ovarian reserve assessment (determined by AMH levels, AFC on day 2 or 3 of menstrual cycle) was done after detailed history and clinical examination. In t r o d u c t I o n\",\"PeriodicalId\":38998,\"journal\":{\"name\":\"International Journal of Infertility and Fetal Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Infertility and Fetal Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5005/jp-journals-10016-1255\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infertility and Fetal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10016-1255","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
21-42岁年龄组的女性,通过卵巢储备标志物确定为高反应者,抗苗勒管激素[AMH≥3.5 ng/mL和/或窦卵泡计数(AFC)≥20,>14个中间卵泡和/或高血清雌二醇(E2)水平(>3500 pg/mL]在触发当天,包括间隔12小时接受两剂激动剂触发。患有下丘脑闭经和促性腺功能减退症的女性被排除在外。因此,对86名符合筛选标准的女性进行了分析。在详细的病史和临床检查后进行卵巢储备评估(通过AMH水平、月经周期第2或第3天的AFC确定)。在t r o d u c t I o n
Impact of Two Doses of Agonist Trigger on Assisted Reproductive Technology Outcome
women in the age-group of 21–42 years, identified as hyperresponders by ovarian reserve markers, anti-Mullerian Hormone [AMH ≥3.5 ng/mL and or antral follicle count (AFC) of ≥20, >14 intermediary follicles and/or a high serum estradiol (E2) level (>3500 pg/mL] on the day of trigger, receiving two doses of agonist trigger 12-hour apart were included. Women with hypothalamic amenorrhea and hypogonadotropic-hypogonadism were excluded. So 86 women fulfilling the selection criteria were analyzed. Ovarian reserve assessment (determined by AMH levels, AFC on day 2 or 3 of menstrual cycle) was done after detailed history and clinical examination. In t r o d u c t I o n